I. Ali

发表

Comparative molecular genetic profiles of anaplastic astrocytomas/ glioblastomas multiforme and their subsequent recurrences

A. Saxena, Lynn M Shriml, M. Dean, 1999, Oncogene.

Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia

Iqbal Unnisa Ali, Charles Theillet, Rosette Lidereau, 1987 .

Effects of cytochalasin B and colchicine on attachment of a major surface protein of fibroblasts.

R. Hynes, I. Ali, 1977, Biochimica et biophysica acta.

Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma.

R. Lidereau, I. Ali, R. Callahan, 1989, Journal of the National Cancer Institute.

Comparative analysis of p21 proteins from various cell types by two‐dimensional gel electrophoresis

I. Ali, N. Feuerstein, 1985, Journal of cellular biochemistry.

Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas.

E. Oldfield, A. Saxena, I. Ali, 1992, Cancer research.

Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines.

A. Saxena, I. Ali, 1992, Oncogene.

Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.

T. Veenstra, B. Luke, T. Conrads, 2006, Oncology reports.

Proteomic Profiling Identifies Cyclooxygenase-2-Independent Global Proteomic Changes by Celecoxib in Colorectal Cancer Cells

Zhen Xiao, I. Ali, P. Greenwald, 2006, Cancer Epidemiology Biomarkers & Prevention.

hOGG1 Genotype, Green Tea and Oxidative DNA Damage among Heavy Smokers

M. Dean, I. Ali, Robin B Harris, 2004 .

Restoration of normal morphology, adhesion and cytoskeleton in transformed cells by addition of a transformation-sensitive surface protein

R. Hynes, I. Ali, V. Mautner, 1977, Cell.

The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.

G. Merlo, R. Lidereau, I. Ali, 1989, Oncogene.

Novel Endogenous Retroviral Genomes in Human Genomic DNA

R. Mariani-Costantini, J. Schlom, I. Ali, 1986 .

Heterogeneity of subcellular localization of p53 protein in human glioblastomas.

E. Oldfield, A. Saxena, I. Ali, 1994, Cancer research.

Amplification of the int-2 gene in primary human breast tumors.

G. Peters, R. Lidereau, I. Ali, 1988, Oncogene research.

Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene.

G. Chrousos, E. Oldfield, C. Stratakis, 1996, The Journal of clinical endocrinology and metabolism.

Lack of evidence for the prognostic significance of c-erbB-2 amplification in human breast carcinoma.

R. Lidereau, I. Ali, R. Callahan, 1988, Oncogene research.

Structural comparison of fibronectins from normal and transformed cells.

T. Hunter, I. Ali, 1981, The Journal of biological chemistry.

The Organization of Mouse Mammary Tumor Virus Related Sequences in Human Cellular DNA

J. Schlom, I. Ali, R. Callahan, 1985 .

LETS glycoprotein: arrangement and function at the cell surface.

R. Hynes, I. Ali, V. Mautner, 1978, Birth defects original article series.

Synthesis, secretion, and attachment of LETS glycoprotein in normal and transformed cells.

R. Hynes, I. Ali, V. Mautner, 1977, Journal of supramolecular structure.

A LARGE GLYCOPROTEIN LOST FROM THE SURFACES OF TRANSFORMED CELLS *

R. Hynes, D. Wagner, I. Ali, 1978, Annals of the New York Academy of Sciences.

Gatekeeper for endometrium: the PTEN tumor suppressor gene.

I. Ali, 2000, Journal of the National Cancer Institute.

Suppressor Gene

I. Ali, 2022 .

Role of disulfide bonds in the attachment and function of large, external, transformation-sensitive glycoprotein at the cell surface.

R. Hynes, I. Ali, 1978, Biochimica et biophysica acta.

Effects of LETS glycoprotein on cell motility

R. Hynes, I. Ali, 1978, Cell.

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.

L. Schriml, M. Dean, I. Ali, 1999, Journal of the National Cancer Institute.

Human normal and tumor cell lines: comparison of fibronectins and collagens.

I. Ali, S. Rasheed, I U Ali, 1987, Cancer investigation.

Heterogeneity of genetic alterations in primary human breast tumors.

R. Lidereau, I. Ali, R. Callahan, 1988, Cancer treatment and research.

Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin

A. Feldman, S. Libutti, I. Ali, 2002, International journal of cancer.

Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

W. Reinhold, E. Oldfield, A. Saxena, 1993, The Journal of clinical investigation.

Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials.

I. Ali, D. Senger, L. E. Smith, 2001, Urology.

Altered Gene Expression Profiles Define Pathways in Colorectal Cancer Cell Lines Affected by Celecoxib

R. Stephens, M. Yi, I. Ali, 2008, Cancer Epidemiology Biomarkers & Prevention.

Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas.

A. Saxena, I. Ali, A Saxena, 1996, Oncogene.

Molecular profiling of angiogenesis markers.

Lois E. H. Smith, K. Desai, I. Ali, 2002, The American journal of pathology.

Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors.

E. Oldfield, T. Fleming, S. Aaronson, 1992, Cancer research.

The current status of int genes, proto-oncogenes, and recessive mutations in primary human breast tumors: their potential usefulness in prognosis

R. Lidereau, I. Ali, R. Callahan, 1989 .

Angiogenesis: A Promising Target for Cancer Prevention

I. Ali, 2003 .

Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.

E. Oldfield, I. Ali, B. Allolio, 1991, The Journal of clinical endocrinology and metabolism.

Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia.

R. Lidereau, I. Ali, C. Theillet, 1987, Science.

Clonal composition of glioblastoma multiforme.

E. Oldfield, A. Saxena, I. Ali, 1992, Journal of neurosurgery.

Effect of a 4-Month Tea Intervention on Oxidative DNA Damage among Heavy Smokers

M. Dean, I. Ali, Robin B Harris, 2004, Cancer Epidemiology Biomarkers & Prevention.

Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.

Asad Umar, Thomas P Conrads, Peter Greenwald, 2004, Cancer research.

Allelic deletions on chromosome-17 and mutations in the p53 gene in tumors metastatic to brain.

E. Oldfield, A. Saxena, I. Ali, 1994, International journal of oncology.

Technical Advance Molecular Profiling of Angiogenesis Markers

Lois E. H. Smith, K. Desai, I. Ali, 2002 .

Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients.

Ming Yi, Iqbal Unnisa Ali, Peter Greenwald, 2009, Cancer genomics & proteomics.

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma

B. Luke, M. Dean, I. Ali, 2005, British Journal of Cancer.

T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.

I. Ali, C. Perruzzi, D. Senger, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Suppressor Gene

I. Ali, 2022 .